Growth Metrics

Cabot (CBT) Cash & Equivalents (2016 - 2025)

Cabot (CBT) has disclosed Cash & Equivalents for 17 consecutive years, with $230.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 25.68% to $230.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $230.0 million through Dec 2025, up 25.68% year-over-year, with the annual reading at $258.0 million for FY2025, 15.7% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $230.0 million at Cabot, down from $258.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $258.0 million in Q3 2025, with the low at $146.0 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $207.0 million, with a median of $207.0 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents surged 47.26% in 2022, then dropped 25.0% in 2024.
  • Over 5 years, Cash & Equivalents stood at $179.0 million in 2021, then rose by 6.15% to $190.0 million in 2022, then increased by 28.42% to $244.0 million in 2023, then decreased by 25.0% to $183.0 million in 2024, then grew by 25.68% to $230.0 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $230.0 million, $258.0 million, and $239.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.